Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-25 @ 3:28 AM
Ignite Modification Date: 2025-12-26 @ 2:08 AM
NCT ID: NCT03581305
Description: the definition of adverse event and/or serious adverse event, used to collect adverse event information, does not differ from the clinicaltrials.gov
Frequency Threshold: 0
Time Frame: 90 minutes of scanning
Study: NCT03581305
Study Brief: PET Imaging of the Dopaminergic and Serotonergic Systems in Treated HIV Positive Subjects
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
HIV Positive Subjects 25 eligible HIV-infected individuals for the dopaminergic arm 18F-FDOPA: High resolution positron emission tomography (PET) of the brain and radioligands targeted against the dopaminergic (18F-FDOPA) system. 20 HIV-infected individuals for the serotonergic arm 11C-DASB: High resolution positron emission tomography (PET) of the brain and radioligands targeted against the serotonergic (11C-DASB) system. 0 None 0 23 0 23 View
HIV Negative Subjects 50 eligible HIV-negative individuals for the dopaminergic arm 18F-FDOPA: High resolution positron emission tomography (PET) of the brain and radioligands targeted against the dopaminergic (18F-FDOPA) system. 20 HIV-infected individuals and 20 HIV-negative individuals for the serotonergic arm 11C-DASB: High resolution positron emission tomography (PET) of the brain and radioligands targeted against the serotonergic (11C-DASB) system. 0 None 0 23 0 23 View
Serious Events(If Any):
Other Events(If Any):